These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30830446)

  • 1. Glycosphingolipids promote pro-atherogenic pathways in the pathogenesis of hyperglycemia-induced accelerated atherosclerosis.
    Dang VT; Zhong LH; Huang A; Deng A; Werstuck GH
    Metabolomics; 2018 Jul; 14(7):92. PubMed ID: 30830446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucosamine-supplementation promotes endoplasmic reticulum stress, hepatic steatosis and accelerated atherogenesis in apoE-/- mice.
    Beriault DR; Sharma S; Shi Y; Khan MI; Werstuck GH
    Atherosclerosis; 2011 Nov; 219(1):134-40. PubMed ID: 21855875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Plasma Metabolomic Analyses of Atherosclerotic Progression Reveal Alterations in Glycerophospholipid and Sphingolipid Metabolism in Apolipoprotein E-deficient Mice.
    Dang VT; Huang A; Zhong LH; Shi Y; Werstuck GH
    Sci Rep; 2016 Oct; 6():35037. PubMed ID: 27721472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence supporting a role for endoplasmic reticulum stress in the development of atherosclerosis in a hyperglycaemic mouse model.
    Khan MI; Pichna BA; Shi Y; Bowes AJ; Werstuck GH
    Antioxid Redox Signal; 2009 Sep; 11(9):2289-98. PubMed ID: 19548776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model.
    Werstuck GH; Khan MI; Femia G; Kim AJ; Tedesco V; Trigatti B; Shi Y
    Diabetes; 2006 Jan; 55(1):93-101. PubMed ID: 16380481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis.
    Bowes AJ; Khan MI; Shi Y; Robertson L; Werstuck GH
    Am J Pathol; 2009 Jan; 174(1):330-42. PubMed ID: 19095952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic reticulum stress and glycogen synthase kinase-3β activation in apolipoprotein E-deficient mouse models of accelerated atherosclerosis.
    McAlpine CS; Bowes AJ; Khan MI; Shi Y; Werstuck GH
    Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):82-91. PubMed ID: 21998135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis.
    Duan W; Paka L; Pillarisetti S
    Cardiovasc Diabetol; 2005 Oct; 4():16. PubMed ID: 16207378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice.
    Reaven P; Merat S; Casanada F; Sutphin M; Palinski W
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2250-6. PubMed ID: 9351397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-Specific Differences in an ApoE(-/-):Ins2(+/Akita) Mouse Model of Accelerated Atherosclerosis.
    Venegas-Pino DE; Wang PW; Stoute HK; Singh-Pickersgill NA; Hong BY; Khan MI; Shi Y; Werstuck GH
    Am J Pathol; 2016 Jan; 186(1):67-77. PubMed ID: 26597883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral chromium picolinate impedes hyperglycemia-induced atherosclerosis and inhibits proatherogenic protein TSP-1 expression in STZ-induced type 1 diabetic ApoE
    Ganguly R; Sahu S; Ohanyan V; Haney R; Chavez RJ; Shah S; Yalamanchili S; Raman P
    Sci Rep; 2017 Mar; 7():45279. PubMed ID: 28345659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity.
    Keren P; George J; Shaish A; Levkovitz H; Janakovic Z; Afek A; Goldberg I; Kopolovic J; Keren G; Harats D
    Diabetes; 2000 Jun; 49(6):1064-9. PubMed ID: 10866061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased atherosclerosis in streptozotocin-induced diabetic mice.
    Kunjathoor VV; Wilson DL; LeBoeuf RC
    J Clin Invest; 1996 Apr; 97(7):1767-73. PubMed ID: 8601643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette-smoke-induced atherogenic lipid profiles in plasma and vascular tissue of apolipoprotein E-deficient mice are attenuated by smoking cessation.
    Lietz M; Berges A; Lebrun S; Meurrens K; Steffen Y; Stolle K; Schueller J; Boue S; Vuillaume G; Vanscheeuwijck P; Moehring M; Schlage W; De Leon H; Hoeng J; Peitsch M
    Atherosclerosis; 2013 Jul; 229(1):86-93. PubMed ID: 23669247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Dimethyl Fumarate on Atherosclerosis in the Apolipoprotein E-Deficient Mouse Model with Streptozotocin-Induced Hyperglycemia Mediated By the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Response Element (Nrf2/ARE) Signaling Pathway.
    Luo M; Sun Q; Zhao H; Tao J; Yan D
    Med Sci Monit; 2019 Oct; 25():7966-7975. PubMed ID: 31645538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice.
    Veerman KJ; Venegas-Pino DE; Shi Y; Khan MI; Gerstein HC; Werstuck GH
    Atherosclerosis; 2013 Apr; 227(2):250-8. PubMed ID: 23411040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models for studies of cardiovascular complications of type 1 diabetes.
    Shen X; Bornfeldt KE
    Ann N Y Acad Sci; 2007 Apr; 1103():202-17. PubMed ID: 17376839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
    Bietrix F; Lombardo E; van Roomen CP; Ottenhoff R; Vos M; Rensen PC; Verhoeven AJ; Aerts JM; Groen AK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):931-7. PubMed ID: 20167657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term type 1 diabetes mellitus creates a pro-atherogenic environment conducive to early atherosclerosis in rats.
    Vântu A; Ghertescu D; Fiscă C; Mărginean A; Hutanu A; Gheban D; Perian M; Serban RC; Scridon A
    Malays J Pathol; 2019 Apr; 41(1):25-32. PubMed ID: 31025634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic vascular disease and the potential role of macrophage glucose metabolism.
    Nishizawa T; Bornfeldt KE
    Ann Med; 2012 Sep; 44(6):555-63. PubMed ID: 21679104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.